Navigation Links
Amira Pharmaceuticals to Present at Thomas Weisel Partners Healthcare Conference
Date:9/3/2009

SAN DIEGO, Sept. 3 /PRNewswire/ -- Amira Pharmaceuticals, Inc., a small molecule pharmaceutical company focused on the discovery and early development of new drugs to treat inflammatory disease, announced today that Robert Baltera, Chief Executive Officer, will present a company overview at the Thomas Weisel Partners Healthcare Conference. The presentation is scheduled for 8:35 a.m. EDT on Wednesday, September 9, 2009, at The Four Seasons Hotel in Boston.

About Amira

Founded in 2005 and headquartered in San Diego, Amira Pharmaceuticals is a small molecule pharmaceutical company focused on the discovery and early development of new drugs to treat inflammatory disease. Our discovery team is building on unparalleled insights into bioactive lipid pathways and complex signaling processes controlling many conditions including asthma, chronic obstructive pulmonary disease, cardiovascular and fibrotic diseases. Amira has a partnership with GlaxoSmithKline for the development of FLAP (5-lipoxygenase activating protein) inhibitors in respiratory and cardiovascular disease.

Amira combines the rigor of a big pharmaceutical company with the ingenuity and energy of a small company, creating an environment for efficient development of novel compounds and effective pre-clinical and clinical program decisions. Its scientific founders have successfully worked together for more than a decade and were pivotal in the discovery of a number of inflammatory drugs, including Singulair(R). The drug hunters at Amira are now actively leveraging their history of success to create high-value compounds for the future. For more information, visit www.amirapharm.com.


'/>"/>
SOURCE Amira Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Amira Pharmaceuticals Announces Favorable Phase 1 Clinical Trial Results for Lead Product Candidate AM103 and Initiates Clinical Studies for the 2nd Entry Molecule for the Treatment of Respiratory and Cardiovascular Disease
2. Amira Pharmaceuticals Appoints First Vice President of Development
3. Amira Pharmaceuticals and GlaxoSmithKline Enter Global Agreement for FLAP Inhibitor Program
4. Dr. Dennis Fenton and Dr. Steve Kaldor Join Amira Board of Directors
5. Amira Pharmaceuticals Achieves Milestones in FLAP Inhibitor Program With GlaxoSmithKline
6. Amira Announces the Successful Completion of GLP Toxicity Studies for a Novel DP2 Antagonist.
7. Amira Pharmaceuticals, Inc. Expands its Scientific Advisory Board and Appoints Dr. Paul Anderson, Professor Jerold Chun and Professor Andrew Tager
8. Amira Pharmaceuticals to Present Preclinical Data from LPA1 Receptor Antagonist Program at FASEB Summer Research Conference
9. Amira Pharmaceuticals Announces Initial Positive Phase 1 Clinical Data for AM211, a Novel Product Candidate for the Treatment of Respiratory Diseases
10. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
11. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2015)... (PRWEB) March 28, 2015 How best ... a growing field in orthopaedic medicine. While diagnostic hip ... to confirm the pain etiology, research presented today at ... ) Specialty Day suggests that pain relief from this ... hip surgery. , “Our study looked to assess ...
(Date:3/28/2015)... Andrew Hawley of Vintage Rock Posters Inc., ... posters. The Who and the Doors played together at the ... According to Hawley, “The Who toured the United States heavily ... campuses. Perhaps the most famous Who poster was a poster ... Doors on August 2, 1968 at the Singer Bowl in ...
(Date:3/28/2015)... The "Petrick Sustainable Health System" ... After 18 years of research and experience with patients ... Dr. Jon Petrick is excited to be launching his ... the immediate benefits of this radical new system are ... strength of the immune system, faster healing of injuries, ...
(Date:3/28/2015)... Servpro of Paso Robles , ... report about the link between mold and asthma. Mold ... to recent medical research, may even cause asthma in ... Protection Agency, people with sensitivity to mold or mold ... trigger asthma attacks for asthma sufferers. The EPA recommends ...
(Date:3/27/2015)... In her mid-forties and with a lifelong ... Monica K. arrived at JET Uniform & Supply ... and scared. The owners and staff at JET, which had ... to offer jobs to challenged residents like Monica, were patient. ... to begin with the end in mind,” says Stephen Milaney, ...
Breaking Medicine News(10 mins):Health News:Pain Injections for Hip Arthroscopy Patients May Not Predict Surgical Outcomes 2Health News:Avid Collector from Vintage Rock Posters, Inc. Announces His Search For Original 1960's Who Psychedelic Concert Posters. 2Health News:Celebrity Chiropractor Jon Petrick to Release Sustainable Health System this Summer 2Health News:Water Damage Restoration Specialists Servpro of Paso Robles Release Report on Mold and Asthma 2Health News:Water Damage Restoration Specialists Servpro of Paso Robles Release Report on Mold and Asthma 3Health News:Red Deer Uniforms Shop Celebrates 3rd Year Sewing Hope for the Challenged 2Health News:Red Deer Uniforms Shop Celebrates 3rd Year Sewing Hope for the Challenged 3
... Rock Enterprises President and Chief,Operating Officer Matthew P. ... Metropolitan Detroit. Cullen succeeds Bill Baer, president and,chief executive ... of the work the YMCA does throughout the Metro ... said. "The YMCA has been a vital part of ...
... ... Market, BEDFORD, Mass. and ... Mass., announced today that it,has signed a definitive agreement to acquire Third ... per share, or approximately,$580 million in value, representing an approximately 24% premium ...
... pressure monitoring and pedometer drivers allow consumers to ... health information via HealthVault, BANNOCKBURN, Ill., June ... relationship to support Microsoft HealthVault,Microsoft,s consumer health platform, ... and a pedometer (HJ-720ITC) to be,compatible and share ...
... will be presented on Monday at SLEEP 2008, the ... (APSS), finds that poor sleep is a problem in ... Julie L. Elam, of Indiana University, was based on ... 48 years. Seventy-six percent of the participants were ...
... negative effect on a student academically, the sleep variables ... to a research abstract that will be presented on ... the Associated Professional Sleep Societies (APSS). , The study, ... Colorado, focused on 98 junior high, 67 high school, ...
... be presented on Monday at SLEEP 2008, the 22nd Annual ... first description of nicotine use by narcolepsy patients. Because ... even while eating, walking or driving, those who smoke nicotine ... themselves or the objects around them, or starting a fire, ...
Cached Medicine News:Health News:Cullen Elected to Chairman of YMCA of Metro Detroit - the City's Oldest Not-for-Profit 2Health News:Hologic to Acquire Third Wave Technologies 2Health News:Hologic to Acquire Third Wave Technologies 3Health News:Hologic to Acquire Third Wave Technologies 4Health News:Hologic to Acquire Third Wave Technologies 5Health News:Hologic to Acquire Third Wave Technologies 6Health News:Hologic to Acquire Third Wave Technologies 7Health News:Hologic to Acquire Third Wave Technologies 8Health News:Hologic to Acquire Third Wave Technologies 9Health News:Hologic to Acquire Third Wave Technologies 10Health News:Omron Healthcare Introduces New Device Drivers Built on Microsoft HealthVault 2Health News:Omron Healthcare Introduces New Device Drivers Built on Microsoft HealthVault 3Health News:Poor sleep a problem in long-term breast cancer survivors 2Health News:Sleep variables affecting school performance are different with each educational level 2Health News:Potential dangers faced by narcoleptics who use nicotine outlined in new abstract 2
(Date:3/27/2015)... Zimmer Holdings, Inc. (NYSE and SIX: ZMH) is launching a ... Available in both small (6mm) and large (11mm) ... from Zimmer is a modular system that offers surgeons advances ... System allows surgeons to eliminate steps, as well as ... saved time, costs and overall team effort. "The ...
(Date:3/27/2015)... , March 27, 2015 Report ... for leading ophthalmic drug companies  What does ... pharma ophthalmic industry ? Visiongain,s brand new report shows ... and prospects there. Our 242-page report provides ... areas in the industry and the future market prospects. ...
(Date:3/27/2015)... As of February, InControl Medical, LLC ... women. "Shipping thousands of our devices ... the hundreds of letters, emails and phone calls ... positively impacted by our technology," said Herschel ... recently released Apex, an over-the-counter solution for female ...
Breaking Medicine Technology:Zimmer Debuts New Modular External Fixation System 2Zimmer Debuts New Modular External Fixation System 3Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 2Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 3Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 4Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 5Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 6Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 7InControl Medical Surpasses 40,000 Shipments Of Incontinence Devices For Women 2
... And, No-Cost, Noninvasive Tool Detects Risk for Undiagnosed ... Seven Years, ALEXANDRIA, Va., April 28 ... with undiagnosed diabetes,identify whether they likely have the ... costs and complications associated with this now,epidemic illness, ...
... Fla., April 27 Calvin A. Grant, ... his 60-patient,retrospective case control study that was ... (bromfenac 0.09mg ophthalmic solution) in Lucentis(R),(ranibizumab) treatment ... (AMD) in an oral poster presentation at,the ...
Cached Medicine Technology:Drug Combo Could Lower Diabetes Complications and Costs 2Drug Combo Could Lower Diabetes Complications and Costs 3Drug Combo Could Lower Diabetes Complications and Costs 4Drug Combo Could Lower Diabetes Complications and Costs 5Dr. Calvin Grant Presents Results from Xibrom(TM) Combination Therapy with Lucentis(R) at the 2008 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) 2Dr. Calvin Grant Presents Results from Xibrom(TM) Combination Therapy with Lucentis(R) at the 2008 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) 3Dr. Calvin Grant Presents Results from Xibrom(TM) Combination Therapy with Lucentis(R) at the 2008 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) 4
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: